Mucartrin

**Mukartrin** is a biogenic agent from the group of glycosaminoglycans that protect cartilage tissue, stimulating the processes of regeneration and restoration of cartilage tissue. It begins to be actively absorbed in the animal's body 30 minutes after injection or instillation, reaching maximum concentrations after 24 hours. It is eliminated from the body relatively slowly - the half-life is about 24 days.

The drug is intended for resorption of contractures and restoration of functions of the musculoskeletal system. The disadvantage of this drug is that its use is prohibited for patients with hemostasis disorders, which are accompanied by an increased risk of bleeding. In addition, Mukartrin can cause severe bleeding, which can lead to negative consequences. When taken together with certain medications (heparin, aspirin, warfarin), this drug may cause complications such as bleeding and blood clots.